Kairos Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Kairos Pharma and other ETFs, options, and stocks.About KAPA
Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology.
CEOJohn S. Yu
CEOJohn S. Yu
Employees4
Employees4
HeadquartersLos Angeles, California
HeadquartersLos Angeles, California
Founded2013
Founded2013
Employees4
Employees4
KAPA Key Statistics
Market cap25.72M
Market cap25.72M
Price-Earnings ratio-3.75
Price-Earnings ratio-3.75
Dividend yield—
Dividend yield—
Average volume876.93K
Average volume876.93K
High today$1.26
High today$1.26
Low today$1.16
Low today$1.16
Open price$1.23
Open price$1.23
Volume729.07K
Volume729.07K
52 Week high$4.00
52 Week high$4.00
52 Week low$0.40
52 Week low$0.40
People also own
Based on the portfolios of people who own KAPA. This list is generated using Robinhood data, and it’s not a recommendation.